CODX - CIK 0001692415
The table below shows Co-Diagnostics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $11.88M | $2.94M | $14.92M | $22.97M | $88.61M | $42.98M |
| Short-term investments | $26.81M | $26.81M | $43.63M | $58.29M | $1.26M | $4.34M |
| Receivables | $190.38K | $132.57K | $303.93K | $3.45M | $20.84M | $12.14M |
| Inventory | $992.40K | $1.07M | $1.66M | $5.31M | $2.00M | $8.00M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $13.69M |
| $32.29M |
| $62.14M |
| $92.73M |
| $115.12M |
| $68.36M |
| Property, plant & equipment | $2.27M | $2.76M | $3.04M | $2.54M | $1.93M | $949.64K |
| Goodwill | - | - | $14.71M | $14.71M | $14.71M | - |
| Total assets | $24.74M | $64.00M | $95.32M | $123.09M | $160.03M | $71.24M |
| Accounts payable | $1.88M | $3.29M | $1.48M | $952.30K | $607.51K | $598.32K |
| Total current liabilities | $3.54M | $7.32M | $5.75M | $3.87M | $12.60M | $4.51M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $4.11M | $9.69M | $9.31M | $8.57M | $25.56M | $4.54M |
| Retained earnings | -$80.37M | -$33.04M | $4.60M | $39.93M | $54.17M | $17.51M |
| Total equity | $20.63M | $54.31M | $86.01M | $114.52M | $134.48M | $66.70M |